News from the FDA/CDC

Progress report: Elimination of neonatal tetanus


 

FROM MMWR

Worldwide cases of neonatal tetanus fell by 90% from 2000 to 2018, deaths dropped by 85%, and 45 countries achieved elimination of maternal and neonatal tetanus (MNT), according to the Centers for Disease Control and Prevention.

“Despite this progress, some countries that achieved elimination are still struggling to sustain performance indicators; war and insecurity pose challenges in countries that have not achieved MNT elimination,” Henry N. Njuguna, MD, of the CDC’s global immunization division, and associates wrote in the Morbidity and Mortality Weekly Report.

Other worldwide measures also improved from 2000 to 2018: Coverage among women of reproductive age with two doses of tetanus toxoid or two doses of tetanus-diphtheria toxoid increased from 62% to 72%, and the percentage of deliveries attended by a skilled birth attendant increased from 62% during 2000-2005 to 81% in 2013-2018, they reported.

The MNT elimination initiative, which began in 1999 and targeted 59 priority countries, immunized approximately 154 million women of reproductive age with at least two doses of tetanus toxoid–containing vaccine from 2000 to 2018, the investigators wrote, based on data from the World Health Organization and the United Nations Children’s Fund.

With 14 of the priority countries – including Nigeria, Pakistan, and Yemen – still dealing with MNT, however, numerous challenges remain, they noted. About 47 million women and their babies are still unprotected, and 49 million women have not received tetanus toxoid–containing vaccine.

This lack of coverage “can be attributed to weak health systems, including conflict and security issues that limit access to vaccination services, competing priorities that limit the implementation of planned MNT elimination activities, and withdrawal of donor funding,” Dr. Njuguna and associates wrote.

SOURCE: Njuguna HN et al. MMWR. 2020 May 1;69(17):515-20.

Recommended Reading

Addressing CVD’s role in U.S. maternal mortality: Multispecialty collaboration is needed
MDedge ObGyn
COVID-19: Press pause on assisted reproduction?
MDedge ObGyn
N.Y. universal testing: Many COVID-19+ pregnant women are asymptomatic
MDedge ObGyn
Itchy, vesicular rash
MDedge ObGyn
COVID-19 registry tracks pregnant women, newborns
MDedge ObGyn
Vaginal cleansing at cesarean delivery works in practice
MDedge ObGyn
Postcesarean recovery protocols reduce opioid use
MDedge ObGyn
Decreased fetal movement: Time to educate patients and ourselves
MDedge ObGyn
Ob.gyns., peds, other PCPs seeking COVID-19 financial relief from feds
MDedge ObGyn
COVID-19 and pregnancy: Is miscarriage a risk?
MDedge ObGyn